Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.25.1
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Costs and expenses:    
Cost of sales $ (342)  
Research and development (591) $ (3,977)
General and administrative (2,777) (2,186)
Total operating expenses (3,710) (6,163)
Operating loss (3,710) (6,163)
Interest expense, net (534) (487)
Adjustments to fair value of derivatives (549) (386)
Other expense, net (38) (17)
Total other expense (1,121) (890)
Loss before income taxes (4,831) (7,053)
Income tax expense (60) (48)
Net loss $ (4,891) $ (7,101)
Net loss per share - basic $ (0.14) $ (0.46)
Net loss per share - diluted $ (0.14) $ (0.46)
Weighted average ordinary shares outstanding - basic 34,059,630 15,432,693
Weighted average ordinary shares outstanding - diluted 34,059,630 15,432,693
Other comprehensive income:    
Net loss $ (4,891) $ (7,101)
Unrealized loss on marketable securities 0 (1)
Comprehensive loss $ (4,891) $ (7,102)